EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C16H26GdN5O8 |
| Net Charge | 0 |
| Average Mass | 573.661 |
| Monoisotopic Mass | 574.10224 |
| SMILES | CNC1=[O][Gd+3]234567[O]=C(NC)C[N]2(CC[N]3(CC[N]4(CC(=O)[O-]5)C1)CC(=O)[O-]6)CC(=O)[O-]7 |
| InChI | InChI=1S/C16H29N5O8.Gd/c1-17-12(22)7-20(10-15(26)27)5-3-19(9-14(24)25)4-6-21(11-16(28)29)8-13(23)18-2;/h3-11H2,1-2H3,(H,17,22)(H,18,23)(H,24,25)(H,26,27)(H,28,29);/q;+3/p-3 |
| InChIKey | HZHFFEYYPYZMNU-UHFFFAOYSA-K |
| Wikipedia |
|---|
| Roles Classification |
|---|
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| gadodiamide (CHEBI:37333) has role MRI contrast agent (CHEBI:37335) |
| gadodiamide (CHEBI:37333) is a gadolinium coordination entity (CHEBI:35730) |
| Incoming Relation(s) |
| gadodiamide hydrate (CHEBI:31642) has part gadodiamide (CHEBI:37333) |
| IUPAC Name |
|---|
| [N,N-bis(2-{[(carboxy-κO)methyl][2-(methylamino)-2-(oxo-κO)ethyl]amino-κN}ethyl)glycinato(3−)-κ2N,O]gadolinium |
| Synonyms | Source |
|---|---|
| gadolinium [bis(2-{(carboxylatomethyl)[2-(methylamino)-2-oxoethyl]amino}ethyl)amino]acetate | IUPAC |
| gadolinium 5,8-bis(carboxylatomethyl)-11-[2-(methylamino)-2-oxoethyl]-3-oxo-2,5,8,11-tetraazatridecan-13-oate | IUPAC |
| Manual Xrefs | Databases |
|---|---|
| DB00225 | DrugBank |
| Gadodiamide | Wikipedia |
| Registry Numbers | Sources |
|---|---|
| CAS:131410-48-5 | ChemIDplus |